Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting

Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development

Cuba approves two more locally made COVID vaccines

Cuba on Friday approved two more domestic COVID-19 vaccines for emergency use, the island nation’s medication regulatory body said. The authorization came after a “rigorous evaluation process of the Soberana 02 and Soberana Plus vaccines,”